María Teresa G de Dávila Selected Research

N-glycolylneuraminyllactosylceramide (HD3)

6/2015	Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 Ganglioside in retinoblastoma tumours.
1/2011	Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer.
1/2010	Detection and characterization of N-glycolyated gangliosides in Wilms tumor by immunohistochemistry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

María Teresa G de Dávila Research Topics

Disease

3	Neoplasms (Cancer) 05/2012 - 01/2010
2	Melanoma (Melanoma, Malignant) 01/2011 - 01/2010
2	Breast Neoplasms (Breast Cancer) 01/2011 - 01/2010
1	Retinoblastoma (Glioblastoma, Retinal) 06/2015
1	Neuroblastoma 01/2011
1	Neuroectodermal Tumors (Neuroectodermal Tumor) 01/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2011
1	Wilms Tumor (Wilm's Tumor) 01/2010

Drug/Important Bio-Agent (IBA)

3	N-glycolylneuraminyllactosylceramide (HD3)IBA 06/2015 - 01/2010
2	G(M3) GangliosideIBA 06/2015 - 01/2011
2	Formaldehyde (Formol)FDA Link 01/2011 - 01/2010
2	GangliosidesIBA 01/2011 - 01/2010
2	ParaffinIBA 01/2011 - 01/2010
1	Monoclonal AntibodiesIBA 06/2015
1	Anaplastic Lymphoma KinaseIBA 05/2012
1	VaccinesIBA 01/2011

Therapy/Procedure

2	Immunotherapy 01/2011 - 01/2010
1	Therapeutics 06/2015